Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL107061 | 0.92 | — | — | |
| Lactic Acid SCHEMBL11154522 | 0.92 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL28140463 | 0.92 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL29204818 | 0.92 | — | — | |
| Lactic Acid SCHEMBL28724201 | 0.92 | — | — | |
| Lactic Acid SCHEMBL27866848 | 0.92 | — | — | |
| Lactic Acid SCHEMBL1995735 | 0.92 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL5189465 | 0.92 | TP53 (1.00) | — | |
| D-Lactic Acid SCHEMBL14947 | 0.92 | — | — | |
| L-Lactic Acid SCHEMBL16958 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107853552-A | The method of cadmium content in lactic acid sodium chloride collaboration extraction abatement rice meal | 江西省粮油科学技术研究所 | 2018-03-30 | — | — | CN | claimed |
| CN-1943517-B | Reagent kid for self collecting oral mucosa cell and nucleic acid pre-extracting and stablizing storage | LIANHE GENE SCIENCE AND TECHNOLOGY INST SHANGHAI | 2010-11-24 | — | — | CN | claimed |
| CN-1943517-A | Reagent kid for self collecting oral mucosa cell and nucleic acid pre-extracting and stablizing storage | LIANZHONG GENE SCIENCE AND TEC (CN) | 2007-04-11 | — | — | CN | claimed |
| WO-2018183367-A1 | METHODS OF TREATING CYSTIC FIBROSIS IN PATIENTS WITH RESIDUAL FUNCTION MUTATIONS | VAN GOOR FREDRICK F (US) | 2018-10-04 | — | — | WO | disclosed |
| CN-107853552-A | The method of cadmium content in lactic acid sodium chloride collaboration extraction abatement rice meal | 江西省粮油科学技术研究所 | 2018-03-30 | — | — | CN | disclosed |
| CN-107853552-A | The method of cadmium content in lactic acid sodium chloride collaboration extraction abatement rice meal | 江西省粮油科学技术研究所 | 2018-03-30 | — | — | CN | disclosed |
| CN-107853552-A | The method of cadmium content in lactic acid sodium chloride collaboration extraction abatement rice meal | 江西省粮油科学技术研究所 | 2018-03-30 | — | — | CN | disclosed |
| CN-101234116-B | Powder needle injection containing caderofloxacin lactate | HARBIN PHARMACEUTICAL GROUP CO LTD GENERAL PHARMACEUTICAL FACTORY | 2010-11-24 | — | — | CN | disclosed |
| CN-101234115-B | Water needle injection containing caderofloxacin lactate | HARBIN PHARMACEUTICAL GROUP CO LTD GENERAL PHARMACEUTICAL FACTORY | 2010-11-24 | — | — | CN | disclosed |
| CN-1943517-B | Reagent kid for self collecting oral mucosa cell and nucleic acid pre-extracting and stablizing storage | LIANHE GENE SCIENCE AND TECHNOLOGY INST SHANGHAI | 2010-11-24 | — | — | CN | disclosed |
| CN-100579527-C | Compositions containing immunomodulatory compounds for the treatment and management of myelodysplastic syndromes and methods of use | CELGENE CORP | 2010-01-13 | — | — | CN | disclosed |
| CN-101564390-A | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes | CELGENE CORP (US) | 2009-10-28 | — | — | CN | disclosed |
| CN-100453068-C | Injection containing caderofloxacin lactate | HARBIN PHARMACEUTICAL GROUP CO (CN) | 2009-01-21 | — | — | CN | disclosed |
| CN-101234115-A | Water needle injection containing caderofloxacin lactate | HARBIN PHARMACEUTICAL GROUP CO (CN) | 2008-08-06 | — | — | CN | disclosed |
| CN-101234116-A | Powder needle injection containing caderofloxacin lactate | HARBIN PHARMACEUTICAL GROUP CO (CN) | 2008-08-06 | — | — | CN | disclosed |
| CN-1943517-A | Reagent kid for self collecting oral mucosa cell and nucleic acid pre-extracting and stablizing storage | LIANZHONG GENE SCIENCE AND TEC (CN) | 2007-04-11 | — | — | CN | disclosed |
| CN-1875927-A | Injection containing caderofloxacin lactate | HARBIN PHARMACEUTICAL GROUP CO (CN) | 2006-12-13 | — | — | CN | disclosed |
| CN-1868451-A | Injection prepn. contg. cardxacin, and its prepn. method | AOXIN PHARMACEUTICAL SCIENCE & (CN) | 2006-11-29 | — | — | CN | disclosed |
| CN-1713917-A | Compositions containing immunomodulatory compounds for the treatment and management of myelodysplastic syndromes and methods of use | CELGENE CORP (US) | 2005-12-28 | — | — | CN | disclosed |